These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28786775)

  • 1. A simple discharge risk model for predicting 1-year mortality in hospitalised acute decompansated heart failure patients with reduced ejection fraction.
    Karauzum K; Karauzum I; Ural D; Baydemir C; Aktas M; Celikyurt U; Kozdag G; Argan O; Bozyel S; Agir A
    Acta Cardiol; 2018 Apr; 73(2):164-170. PubMed ID: 28786775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discharge risk scoring method for predicting mortality in hospitalized chronic heart failure patients with severe systolic dysfunction.
    Tokatli A; Karauzum K; Ural D; Baydemir C; Kozdag G; Celikyurt U; Akay Y; Argan O; Yilmaz I; Vural A
    Acta Cardiol; 2015 Aug; 70(4):442-9. PubMed ID: 26455247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
    Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
    J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
    Matsumoto K; Ehara S; Nakamura Y; Otsuka K; Kawase Y
    Heart Vessels; 2018 Oct; 33(10):1204-1213. PubMed ID: 29687159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Long-Term Outcomes of Patients with Acute Decompensated Heart Failure with Mid-Range Ejection Fraction.
    Ito M; Wada H; Sakakura K; Ibe T; Ugata Y; Fujita H; Momomura SI
    Int Heart J; 2019 Jul; 60(4):862-869. PubMed ID: 31204376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender Differences in Left Ventricular Ejection Fraction and Outcomes Among Patients Hospitalized for Acute Decompensated Heart Failure.
    Kajimoto K; Minami Y; Sato N; Otsubo S; Kasanuki H;
    Am J Cardiol; 2017 May; 119(10):1623-1630. PubMed ID: 28325570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic Predictors of Mortality in Women With Heart Failure With Reduced Ejection Fraction.
    Lundorff IJ; Sengeløv M; Godsk Jørgensen P; Pedersen S; Modin D; Eske Bruun N; Fritz-Hansen T; Skov Jensen J; Biering-Sørensen T
    Circ Cardiovasc Imaging; 2018 Nov; 11(11):e008031. PubMed ID: 30571317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance.
    Thorvaldsen T; Claggett BL; Shah A; Cheng S; Agarwal SK; Wruck LM; Chang PP; Rosamond WD; Lewis EF; Desai AS; Lund LH; Solomon SD
    Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29242352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction.
    De la Espriella R; Santas E; Miñana G; Bodí V; Valero E; Payá R; Núñez E; Payá A; Chorro FJ; Bayés-Genis A; Sanchis J; Núñez J
    Am J Cardiol; 2017 Oct; 120(8):1344-1348. PubMed ID: 28823484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).
    Caughey MC; Avery CL; Ni H; Solomon SD; Matsushita K; Wruck LM; Rosamond WD; Loehr LR
    Am J Cardiol; 2014 Dec; 114(12):1850-4. PubMed ID: 25438912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction.
    Kajimoto K; Minami Y; Otsubo S; Sato N
    Eur Heart J Acute Cardiovasc Care; 2019 Oct; 8(7):606-614. PubMed ID: 28879773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction.
    Lourenço P; Pereira J; Ribeiro A; Ferreira-Coimbra J; Barroso I; Guimarães JT; Leite-Moreira A; Bettencourt P
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):23-29. PubMed ID: 30407267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.